Currently submitted to: Journal of Medical Internet Research
Date Submitted: Oct 9, 2026
Open Peer Review Period: Oct 11, 2026 - Dec 6, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Discussions of Oral Versus Injectable Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss on Reddit: Content Analysis
ABSTRACT
Through content analysis of 73,740 posts on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) from 44 Reddit communities (October 2025-September 2026), we found the share of oral GLP-1 RA discussion rising from 1.2% to 7.6%. Compared with injectable posts, oral posts more frequently discussed medication-use practice (47.4% vs 40.7%) and cash-pay and direct-to-consumer channels (13.7% vs 8.1%), with less attention to diet, psychosocial concerns, appearance, and comorbidities. These findings suggest oral GLP-1 RAs are framed as consumer goods for self-acquisition and self-management rather than as medical interventions embedded in the body like injectables, a framing that might lower treatment barriers while weakening recognition of obesity as a chronic disease requiring medical management and increasing risks of nonstandard use.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.